Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Nov 1, 2025 | (Q1)Aug 2, 2025 | (FY)May 3, 2025 | (Q4)May 3, 2025 | (Q3)Feb 1, 2025 | (Q2)Nov 2, 2024 | (Q1)Aug 3, 2024 | (FY)May 4, 2024 | (Q4)May 4, 2024 | (Q3)Feb 3, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.79%8B | 1.49%8.26B | 1.77%31.28B | 3.04%7.64B | 3.08%7.73B | 0.35%7.78B | 0.76%8.14B | 0.84%30.73B | 0.05%7.41B | 7.49B |
| Operating revenue | 2.79%8B | 1.49%8.26B | 1.77%31.28B | 3.04%7.64B | 3.08%7.73B | 0.35%7.78B | 0.76%8.14B | 0.84%30.73B | 0.05%7.41B | --7.49B |
| Cost of revenue | 2.36%5.85B | 0.20%6.02B | 1.03%22.9B | 2.26%5.53B | 2.45%5.64B | -0.60%5.71B | 0.17%6.01B | -0.10%22.66B | -0.79%5.41B | 5.51B |
| Gross profit | 3.97%2.15B | 5.13%2.24B | 3.85%8.38B | 5.13%2.11B | 4.82%2.08B | 3.07%2.07B | 2.48%2.13B | 3.57%8.07B | 2.38%2.01B | 1.99B |
| Operating expense | 4.18%1.87B | 3.91%1.89B | 3.72%7.25B | 5.34%1.83B | 2.72%1.81B | 2.62%1.8B | 4.26%1.82B | 4.21%6.99B | 2.70%1.74B | 1.76B |
| Selling and administrative expenses | 4.18%1.87B | 3.91%1.89B | 3.72%7.25B | 5.34%1.83B | 2.72%1.81B | 2.62%1.8B | 4.26%1.82B | 4.21%6.99B | 2.70%1.74B | --1.76B |
| Operating profit | 2.59%277M | 12.22%349M | 4.72%1.13B | 3.77%275.4M | 21.13%274.6M | 6.17%270M | -6.77%311M | -0.36%1.08B | 0.34%265.4M | 226.7M |
| Net non-operating interest income (expenses) | 11.84%-67M | 1.35%-73M | -5.26%-300M | -2.15%-75.9M | -6.13%-74.5M | -7.50%-76M | -6.02%-74M | -5.87%-285M | -4.06%-74.3M | -70.2M |
| Non-operating interest income | 133.33%14M | 14.29%8M | 0.00%28M | -9.64%7.5M | -12.66%6.9M | 1.69%6M | 18.64%7M | 16.67%28M | 38.33%8.3M | --7.9M |
| Non-operating interest expense | -1.25%79M | 0.00%79M | 4.90%321M | 1.48%82.4M | 4.06%79.4M | 7.10%80M | 7.05%79M | 7.22%306M | 8.70%81.2M | --76.3M |
| Total other finance cost | 0.00%2M | 0.00%2M | 0.00%7M | -28.57%1M | 11.11%2M | 5.26%2M | 5.26%2M | -10.26%7M | -48.15%1.4M | --1.8M |
| Other net income (expenses) | -58.82%21M | -40.68%35M | -29.91%164M | 43.77%38.1M | -35.51%15.8M | -14.00%51M | -52.30%59M | 55.28%234M | -54.55%26.5M | 24.5M |
| Gain on sale of security | 50.00%3M | 100.00%2M | 100.00%6M | 75.00%700K | 300.00%2.4M | 66.67%2M | 25.00%1M | 36.36%3M | -66.67%400K | --600K |
| Special income (charges) | --0 | -68.42%12M | -48.98%75M | 124.24%22.2M | -93.62%300K | -64.74%14M | -59.01%38M | 228.86%147M | -72.11%9.9M | --4.7M |
| -Less:Other special charges | ---- | -1,100.00%-10M | 53.85%-18M | ---- | -175.00%-1.1M | 99.74%-100K | --1M | ---39M | --400K | ---400K |
| -Gain on sale of property,plant,equipment | --0 | -94.87%2M | -47.22%57M | -59.22%4.2M | -118.60%-800K | 1,900.00%14M | -57.93%39M | 141.61%108M | -70.99%10.3M | --4.3M |
| Other non-operating income (expenses) | 0.00%4M | 0.00%4M | -54.55%15M | 8.11%4M | -26.09%3.4M | -4.76%4M | -80.49%4M | 104.97%33M | -15.91%3.7M | --4.6M |
| Income before tax | -5.71%231M | 5.07%311M | -3.30%995M | 9.19%237.6M | 19.28%215.9M | 0.86%245M | -23.61%296M | 6.59%1.03B | -13.44%217.6M | 181M |
| Income tax | -4.69%61M | 20.90%81M | -6.39%249M | -3.25%59.6M | 34.25%58.4M | 18.08%64M | -37.21%67M | 11.91%266M | -2.99%61.6M | 43.5M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -6.08%170M | 0.44%230M | -2.23%746M | 14.10%178M | 14.55%157.5M | -4.08%181M | -18.45%229M | 4.85%763M | -16.98%156M | 137.5M |
| Net income continuous operations | -6.08%170M | 0.44%230M | -2.23%746M | 14.10%178M | 14.55%157.5M | -4.08%181M | -18.45%229M | 4.85%763M | -16.98%156M | --137.5M |
| Noncontrolling interests | 37.50%11M | -14.29%18M | 24.32%46M | -15.87%5.3M | 245.45%11.4M | 5.26%8M | 6.06%21M | -11.27%37M | 26.00%6.3M | 3.3M |
| Net income attributable to the company | -8.09%159M | 1.92%212M | -3.58%700M | 15.36%172.7M | 8.87%146.1M | -4.47%173M | -20.31%208M | 5.83%726M | -18.15%149.7M | 134.2M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -8.09%159M | 1.92%212M | -3.58%700M | 15.36%172.7M | 8.87%146.1M | -4.47%173M | -20.31%208M | 5.83%726M | -18.15%149.7M | 134.2M |
| Diluted earnings per share | -5.48%0.69 | 5.81%0.91 | 0.68%2.94 | 21.31%0.74 | 14.81%0.62 | 0.00%0.73 | -17.31%0.86 | 10.19%2.92 | -15.28%0.61 | 0.54 |
| Basic earnings per share | -5.48%0.69 | 5.81%0.91 | 0.34%2.93 | 21.31%0.74 | 14.81%0.62 | 1.39%0.73 | -16.50%0.86 | 10.61%2.92 | -14.08%0.61 | 0.54 |
| Dividend per share | 10.00%0.22 | 10.00%0.22 | 9.59%0.8 | 9.59%0.2 | 9.59%0.2 | 9.59%0.2 | 9.59%0.2 | 10.61%0.73 | 10.61%0.1825 | 0.1825 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.